Mengyuan He

Mengyuan He

Auto-generated profile, based on publicly available information

Mengyuan He

Henan University of Traditional Chinese Medicine, Zhengzhou City, Henan Province, China, Graduate student

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Archives of Biological Sciences
Verified
Journal Article
Open access
PDF file
ZGZhonghua Guo
Zhonghua Guo
MHMengyuan He
Mengyuan He
DSDongliang Shi
Dongliang Shi
ZZZhongbo Zhang
Zhongbo Zhang
LWLisha Wang
Lisha Wang
HYHongchao Yu
Hongchao Yu
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation, leading to pain, swelling, stiffness, and joint damage. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) hold significant promise as therapeutic agents owing to their potent paracrine activities. This study investigated the anti-inflammatory effects of human umbilical cord-derived MSC (hUCSC)-EVs overexpressing miR-124 in collagen-induced arthritis (CIA). hUCSCs were transfected with miR-124, and hUCSC-EVs were isolated and characterized. Arthritis was induced in mice by collagen injection, followed by intravenous administration of miR-124 EVs, miR-control, or vehicle. Cytokine levels, including interleukin (IL)-6, IL-1?, tumor necrosis factor (TNF)-?, IL-10, and transforming growth factor (TGF)-?, were measured in the joints using real-time PCR by enzyme-linked immunosorbent assay (ELISA). miR-124-hUCSC-EVs showed enrichment of miR-124. In arthritic mice, intravenous treatment with miR-124 EVs significantly reduced the clinical score, increased anti-inflammatory cytokines IL-10 and TGF-?, and lowered inflammatory cytokines IL-6, TNF-?, and IL-1? in the joints. This study shows that miR-124 EVs have anti-inflammatory activity in arthritis by suppressing pro-inflammatory cytokines through miR-124 overexpression. MSC-EVs overexpressed with inflammation-modulating miRNAs offer a promising cell-free approach for treating inflammatory arthritis.